Abstract：Objective To explore the pre-pregnancy health risk exposure of men in three regions of Jiangsu Province, and to analyze the pre-pregnancy health risk exposure of men. Methods Using the “core indicators of pre-pregnancy health risk exposure assessment for couples of childbearing age in China”, men in three project cities/counties in southern Jiangsu, central Jiangsu, and northern Jiangsu who participated in free pre-pregnancy eugenic health check in 2015 were used to conduct pre-pregnancy risk exposure assessment and their pre-pregnancy risk were analyzed. Results A total of 11 408 men were included in the study. There was a statistically significant difference in age, ethnicity, education level, occupation, and nature of household registration among people in different regions (P < 0.05). There was a statistically significant difference in the high-risk exposure status of behavioral risk, genetic risk, infectious risk and other risks among people in different regions (P < 0.05). There was a statistically significant difference in the high-risk exposure status of body mass index, blood pressure, heart rate, glutamic-pyruvic transaminase and creatinine among people in different regions (P <0.05). A total of 614 men were assessed as high-risk groups, with a high-risk rate of 5.38%. The top three behavioral risks with the highest risk rate were passive smoking, drinking, and smoking, which were 21.33%, 16.64% and 15.66%, respectively. Conclusion Men in Jiangsu Province are in good health before pregnancy, but there are certain behavioral risk exposures. In order to give birth to healthy children, pre-pregnancy eugenic health checkups are required. Prevent birth defects from the source and promote prenatal and postnatal care.
李新艳 徐宁 张磊 周培莹 吴玉璘 姜志欣 石慧 许豪勤. 江苏省不同地区11 408名男性孕前健康风险的暴露状况[J]. 中国医药导报, 2020, 17(36): 73-76,86.
LI Xinyan XU Ning ZHANG Lei ZHOU Peiying WU Yulin JIANG Zhixin SHI Hui XU Haoqin. Status assessment of preconception health risk exposure among 11 408 males in different areas of Jiangsu Province. 中国医药导报, 2020, 17(36): 73-76,86.
2020, Vol. 17 
京公网安备 11010502046598号